PHILADELPHIA — Michael A. Golden, MD, associate professor of Surgery at the Perelman School of Medicine at the University of Pennsylvania and chief, Division of Vascular Surgery and Endovascular Therapy at Penn Presbyterian Medical Center (PPMC), has been named president of the Eastern Vascular Society (EVS).
“I am honored to serve as President of the Eastern Vascular Society. In order to be the very best at what we do, it is important that we collaborate, mentor our trainees and younger members, and create and share the latest advances and techniques with our colleagues who practice vascular and endovascular surgery in the eastern half of North America,” said Dr. Golden. “The EVS is an organization that helps us do that and work together to deliver the highest quality vascular health care.”
The Eastern Vascular Society is the largest regional vascular society in the U.S., with over 575 members who are primarily vascular surgeons representing both major academic medical centers and community hospitals in the Eastern part of the U.S. and Canada.
Dr. Golden has been a Penn Medicine faculty member for over two decades. As chief of the Division of Vascular Surgery and Endovascular Therapy at PPMC, his clinical interests include evaluation and treatment of patients with aortic, visceral, renal, carotid and peripheral arterial aneurysms and occlusive disease. He has participated in clinical trials involving carotid stenting, lower extremity bypass and thoracic and abdominal aortic aneurysm repair using novel stent grafts. He has also run a National Institutes of Health-funded laboratory, focused on the study of arterial and vein graft wall biology, in order to prevent vessel wall degeneration, vascular stenosis and bypass graft failure.
He received his medical degree from Penn and went on to complete post-graduate and fellowship training in Surgery at the Brigham & Women's Hospital in Boston, MA. He has served on the editorial boards of both Vascular Surgery and The Journal of Vascular Surgery and has authored more than 90 journal articles, reviews and book chapters.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.